Serum albumin: New thoughts on an old treatment

British Columbia Medical Journal

Volumn 47, Issue 8, 2005, Pages 438-444

  Fan, Cynthia ^a   Phillips, Kate ^a   Selin, Shannon ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b British Columbia Provincial Blood Coordinating Office   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 28444452982     PISSN: 00070556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Vermeulen L, Ratko T, Erstad B, et al. A paradigm for consensus. The University Hospital Consortium guidelines for the use of albumin, nonprotein colloid, and crystalloid solutions. Arch Intern Med 1995;155:373-379.
2. Yim J, Vermeulen L, Erstad B, et al. Albumin and nonprotein colloid solution use in US academic health centers. Arch Intern Med 1995;155:2450-2455.
3. Fischer J. When is an albumin infusion needed? Dimens Crit Care Nurs 1999;18:17.
4. Shew KH, Bhavnani M. Human albumin administration in critically ill patients: Some patients may benefit. BMJ 1998; 317:885-886.
5. Devlin JW, Barletta JF. Albumin for fluid resuscitation: Implications of the saline versus albumin fluid evaluation. Am J Health Syst Pharm 2005;62:637-642.
6. Haupt MT, Rackow EC. Colloid osmotic pressure and fluid resuscitation with hetastarch, albumin, and saline solutions. Crit Care Med 1982;10:159-162.
7. Ernest D, Belzberg A, Dodek P. Distribution of normal saline and 5% albumin infusions in septic patients. Crit Care Med 1999;27:46-50.
8. Ernest D, Belzberg A, Dodek P. Distribution of normal saline and 5% albumin infusions in cardiac surgical patients. Crit Care Med 2001;29:2299-2302.
9. Goldwasser P, Feldman J. Association of serum albumin and mortality risk. J Clin Epidemiol 1997;50:693-703.
10. Sort P, Navasa M, Arroyo V, et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999;341:403-409.
11. Human albumin administration in critically ill patients: Systematic review of randomised controlled trials. Cochrane Injuries Group Albumin Reviewers. BMJ 1998;317:235-240.
12. Boldt J. Colloids/crystalloids: Does albumin influence the mortality risk? Trans Alt Trans Med (TATM) 2000;2:5-8.
13. Drummond G, Ludlam C. Is albumin harmful? Br J Haematol 1999;106:266-269.
14. Woodman R. Doctors advised to take special care with human albumin. BMJ 1999;318:1643.
15. Skillman J. Albumin - does the bell toll for thee? Transfusion 1999;39:120-122.
16. Beale R, Wyncoll D, McLuckie A. Human albumin in critically ill patients: Analysis is superficial and conclusions exaggerated. BMJ 1998;317:884.
17. Finfer S, Bellomo R, Boyce N, et al; SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the ICU. N Engl J Med 2004;350:2247-2256.
18. McClelland D. Safety of human albumin as constituent of biologic therapeutic products. Transfusion 1998;38:690-699.
19. Saldanha J, Minor P. Detection of human parvovirus B19 DNA in plasma pools and blood products derived from these pools: Implication for efficiency and consistency of removal of B19 DNA during manufacture. Br J Haematol 1996;93:714-719.
20. Heye N, Hensen S, Muller N. Creutzfeld-Jakob disease and blood transfusion. Lancet 1994;343:298-299.
21. Foster P. Assessment of the potential of plasma fractionation process to remove causative agents of transmissible spongiform encephalopathy. Transfus Med 1999;9:4-14.
22. Tanzi M, Gardner M, Megellas M, et al. Evaluation of the appropriate use of albumin in adult and pediatric patients. Am J Health Syst Pharm 2003;60:1330-1335.
23. Tarin Remohi MJ, Sanchez Arcos A, Santos Ramos B, et al. Costs related to inappropriate use of albumin in Spain. Ann Pharmacother 2000;34:1198-1205.